Zepbound Now Available Through LillyDirect: A New Option for Tirzepatide Access at a Predictable Price
At Clinical Nutrition Center, we’re excited to share a new way for patients to access Zepbound (tirzepatide)—one of the most effective FDA-approved medications for weight loss—without relying on insurance coverage.
In clinical studies, patients treated with higher doses of tirzepatide lost an average of 50 pounds over 72 weeks. However, access has been challenging, with many insurance companies, including CVS/Caremark, recently denying coverage—even after extensive prior authorization efforts by our team.
Now, through LillyDirect’s new cash-pay program, patients can receive brand-name Zepbound shipped directly to their home, without the need for insurance. This is a fast, simple, and reliable option that offers the following pricing:
- 2.5 mg dose: $349/month
- Higher doses (5 mg to 10 mg): $499/month
Currently, doses are available up to 10 mg, and all dose strengths are expected to be available by August.
Already Taking Compounded Tirzepatide?
If you’re currently using compounded tirzepatide, this is an excellent time to consider switching to brand-name Zepbound at a similar monthly cost. The new LillyDirect pricing brings predictable access to the real, FDA-approved medication, backed by Lilly’s research and support.
What You Need to Do
To start Zepbound through LillyDirect, you’ll need to schedule an appointment with your provider at Clinical Nutrition Center. During this visit, we’ll review your current medication, make sure Zepbound is the right fit, and send your prescription directly to LillyDirect.
To learn more or to schedule your visit, contact us at Clinical Nutrition Center or visit LillyDirect for additional information.
